血管平滑肌
血管疾病
外围设备
细胞外基质
平滑肌
解剖
医学
化学
基质(化学分析)
病理
动脉
弹性蛋白
细胞生物学
动脉疾病
血管
基质金属蛋白酶
胫后动脉
循环系统
内科学
疾病
免疫组织化学
动脉硬化
内皮
心肌细胞
后肢
心脏病学
细胞
动脉粥样硬化性血管病
股动脉
腘动脉
内分泌学
作者
Hui-Guang Chen,Di Gao,Zeng Gui-feng,Guo-Ping Zhang,Zi-Yan Yuan,De-Hong Pan,Yi-Kun Qin,Zhong-Yuan Lv,Xiao-Bo Tan,Guo-Tian Chen,Gui-Qing Wang,Da-wei Zhang,Xiao-Dan Xia
标识
DOI:10.1016/j.bbagen.2026.130964
摘要
Vascular smooth muscle cells (VSMCs) dedifferentiation is a key driver of peripheral artery disease (PAD), a common complication of atherosclerosis. Although matrix metallopeptidase 14 (MMP14) has been implicated in promoting VSMC dedifferentiation, the underlying mechanisms remain incompletely defined. Here, we demonstrate that MMP14 expression is markedly increased in PAD plaques, accompanied by elevated platelet-derived growth factor receptor-β (PDGFRβ) and reduced low-density lipoprotein receptor-related protein 6 (LRP6) levels, predominantly within VSMCs, compared with plaque-free arterial segments. Mechanistically, MMP14 selectively promoted LRP6 shedding without affecting LRP5 in VSMCs. Genetic or pharmacological inhibition of MMP14 increased LRP6 abundance, reduced PDGFRβ and SP1 expression, attenuated ERK phosphorylation, and suppressed VSMC proliferation and migration. In contrast, MMP14 overexpression produced opposite effects. Collectively, these findings indicate that MMP14 enhances VSMC proliferation and migration through modulation of the LRP6-PDGFRβ signaling axis.
科研通智能强力驱动
Strongly Powered by AbleSci AI